OLD Category: immuno-oncology
November 2, 2021 / Cancers (Basel)
A Phase Ib Study of Sotrastaurin, a PKC Inhibitor, and Alpelisib, a PI3Kα Inhibitor, in Patients with Metastatic Uveal Melanoma
November 1, 2021 / J Immunother Cancer
BT7480, a novel fully synthetic Bicycle tumor-targeted immune cell agonist™ (Bicycle TICA™) induces tumor localized CD137 agonism
November 1, 2021 / J Immunother Cancer
Synergy between Toxoplasma gondii type I DeltaGRA17 immunotherapy and PD-L1 checkpoint inhibition triggers the regression of targeted and distal tumors
November 1, 2021 / Pac Symp Biocomput
Mixed Effects Machine Learning Models for Colon Cancer Metastasis Prediction using Spatially Localized Immuno-Oncology Markers
November 1, 2021 / J Immunother Cancerbladder cancer
Synergistic antitumor activity of pan-PI3K inhibition and immune checkpoint blockade in bladder cancer
October 29, 2021 / Neuropathol Appl Neurobiol
TUMOUR-ASSOCIATED CD204+ MICROGLIA/MACROPHAGES ACCUMULATE IN PERIVASCULAR AND PERINECROTIC NICHES AND CORRELATE WITH AN INTERLEUKIN-6 ENRICHED INFLAMMATORY PROFILE IN GLIOBLASTOMA
October 28, 2021 / Front Bioeng Biotechnol